+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Biosensors Market Report and Forecast 2023-2031

  • PDF Icon


  • 140 Pages
  • April 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797874
The global Biosensors market value was USD 7.5 billion in 2022, driven by the growing demand for point-of-care testing across the globe. The market size is anticipated to grow at a CAGR of 6.4% during the forecast period of 2023-2031 to achieve a value of USD 13.1 billion by 2031.

Biosensors: Introduction

Biosensors are analytical devices that combine biological ccomponents, such as enzymes or antibodies, with a physicochemical transducer to detect and quantify various biological or chemical analytes. They are designed to convert the biological response generated by a target molecule into a measurable signal, providing real-time, accurate, and sensitive detection.

The main components of a biosensor include a recognition element that selectively interacts with the target analyte, a transducer that converts the biological response into a measurable signal, and a signal processing system that analyzes and presents the data.

Biosensors have found extensive applications in various industries, including healthcare, agriculture, environmental monitoring, food safety, and biodefense. In healthcare, biosensors play a crucial role in medical diagnostics, drug discovery, and patient monitoring. They enable rapid and precise detection of biomarkers, pathogens, and genetic materials, leading to early disease diagnosis, personalized medicine, and improved patient outcomes.

Overall, biosensors are revolutionizing the field of diagnostics and monitoring, offering significant potential for improving healthcare outcomes, enhancing food safety, and protecting the environment. The continuous advancements and increasing commercialization of biosensor technologies are expected to fuel the growth of the global biosensors market in the coming years.

Key Trends in the Biosensors Market

Some key trends in the biosensors market include:

  • Miniaturization and wearable biosensors: There is a growing trend towards the miniaturization of biosensor devices, making them smaller, portable, and suitable for wearable applications. These wearable biosensors offer real-time and continuous monitoring of various health parameters, such as heart rate, glucose levels, and activity tracking. They provide convenience, mobility, and personalized healthcare management
  • Point-of-care testing (POCT): The demand for rapid and on-site testing has fueled the development of biosensors for point-of-care diagnostics. These biosensors enable quick and accurate detection of diseases and analytes in clinical settings, eliminating the need for laboratory-based testing and reducing turnaround time. POCT biosensors are particularly valuable in remote and resource-limited areas, emergency situations, and home healthcare settings
  • Integration with digital health platforms: Biosensors are increasingly integrated with digital health platforms, such as mobile apps and cloud-based systems, allowing for data collection, analysis, and remote monitoring. This integration enables healthcare professionals to track and interpret biosensor data, empowering personalized healthcare management, remote patient monitoring, and telemedicine
Biosensors Market Segmentation

Market Breakup by Product


  • Wristwear
  • Eyewear
  • Footwear
  • Neckwear
  • Bodywear
  • Others
  • Non-Wearable

Market Breakup by Technology


  • Amperometric Sensor
  • Potentiometric Sensor
  • Conductometric Sensor


  • SPR
  • Colorimetric Biosensors
  • Fluorescence Biosensors


  • Acoustic Biosensors
  • Microcantilever Biosensors
  • Thermal Biosensor
  • Nanomechanical

Market Breakup by Component

  • Bioreceptor Molecule
  • Biological Element
  • Transducer

Market Breakup by Application


  • Glucose Monitoring
  • Cardiac Marker
  • Infectious Disease Detection
  • Coagulation Monitoring
  • Pregnancy Testing
  • Blood Gas and Electrolyte Detection
  • Detection of Tumor or Cancer Marker
  • Urinalysis Testing
  • Cholesterol Testing

Home Diagnostic

  • Glucose Monitoring
  • Pregnancy Testing
  • Cholesterol Testing
  • Research Labs
  • Environmental Monitoring
  • Food and Beverages
  • Biodefence

Market Breakup by End User

  • Home Healthcare Diagnostics
  • POC Testing
  • Food Industry
  • Research Laboratories
  • Security and Biodefence

Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Biosensors Market Scenario

The global biosensors market is experiencing significant growth and is poised to revolutionize various industries, including healthcare, agriculture, environmental monitoring, and food safety. Biosensors are innovative analytical devices that combine biological components with transducers to detect and quantify specific analytes in real-time.

In healthcare, biosensors are used for a wide range of applications, including disease diagnosis, monitoring of chronic conditions, drug development, and personalized medicine. They offer several advantages, such as rapid results, high sensitivity, specificity, and the ability to perform on-site testing. Biosensors enable early detection of diseases, facilitate remote patient monitoring, and contribute to more targeted and effective treatments.

The market for biosensors is driven by factors such as the increasing prevalence of chronic diseases, the growing demand for point-of-care testing, and advancements in sensor technology. Additionally, the rise of wearable biosensors and the integration of biosensors with digital health platforms are reshaping the way healthcare is delivered and monitored.

Beyond healthcare, biosensors are gaining traction in areas such as agriculture, where they assist in soil analysis, pesticide detection, and livestock health monitoring. They are also utilized in environmental monitoring to detect pollutants and ensure water quality. The food industry utilizes biosensors for rapid and accurate detection of contaminants and pathogens.

As the demand for rapid, accurate, and portable diagnostic solutions continues to rise, the biosensors market is expected to witness substantial growth in the coming years. The increasing adoption of biosensors in diverse sectors and the development of novel applications will further expand the market opportunities, paving the way for advancements in healthcare, agriculture, environmental monitoring, and beyond.

Biosensors Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • AgaMatrix Holdings LLC
  • Abbott Laboratories Inc
  • Biosensors International Group, Ltd
  • Medtronic Inc
  • Bio-Rad Laboratories Inc
  • Pinnacle Technologies Inc
  • Ercon, Inc
  • Dupont Biosensors Materials
  • Koninklijke Philips N.V
  • Qtl Biodetection Llc
  • Molecular Devices Corporation
  • Nova Biomedical
  • Molex Llc
  • Zimmer & Peacock As
  • Siemens Healthcare

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Biosensors Market Overview
3.1 Global Biosensors Market Historical Value (2016-2022)
3.2 Global Biosensors Market Forecast Value (2023-2031)
4 Global Biosensors Market Landscape
4.1 Global Biosensors Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Biosensors Product Landscape
4.2.1 Analysis by Type of Biosensor
4.2.2 Analysis by Technology Used
4.2.3 Analysis by Applications
5 Global Biosensors Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Biosensors Market Segmentation
6.1 Global Biosensors Market by Product
6.1.1 Market Overview
6.1.2 Wearable Wristwear Eyewear Footwear Neckwear Bodywear Others
6.1.3 Non-Wearable
6.2 Global Biosensors Market by Technology
6.2.1 Market Overview
6.2.2 Electrochemical Amperometric Sensor Potentiometric Sensor Conductometric Sensor
6.2.3 Optical SPR Colorimetric Biosensors Fluorescence Biosensors
6.2.4 Piezoelectric Acoustic Biosensors Microcantilever Biosensors
6.2.5 Thermal Biosensor
6.2.6 Nanomechanical
6.3 Global Biosensors Market by Component
6.3.1 Market Overview
6.3.2 Bioreceptor Molecule
6.3.3 Biological Element
6.3.4 Transducer
6.4 Global Biosensors Market by Application
6.4.1 Market Overview
6.4.2 POC Glucose Monitoring Cardiac Marker Infectious Disease Detection Coagulation Monitoring Pregnancy Testing Blood Gas and Electrolyte Detection Detection of Tumor or Cancer Marker Urinalysis Testing Cholesterol Testing
6.4.3 Home Diagnostic Glucose Monitoring Pregnancy Testing Cholesterol Testing
6.4.4 Research Labs
6.4.5 Environmental Monitoring
6.4.6 Food and Beverages
6.4.7 Biodefence
6.5 Global Biosensors Market by End User
6.5.1 Market Overview
6.5.2 Home Healthcare Diagnostics
6.5.3 POC Testing
6.5.4 Food Industry
6.5.5 Research Laboratories
6.5.6 Security and Biodefence
6.6 Global Biosensors Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Bladder Cancer Treatment Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Bladder Cancer Treatment Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Bladder Cancer Treatment Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Bladder Cancer Treatment Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Bladder Cancer Treatment Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 AgaMatrix Holdings LLC
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Abbott Laboratories Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Biosensors International Group, Ltd.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Medtronic Inc.
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Bio-Rad Laboratories Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Pinnacle Technologies Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Ercon, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Dupont Biosensors Materials
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Koninklijke Philips N.V.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Qtl Biodetection Llc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Molecular Devices Corporation
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Nova Biomedical
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Molex Llc
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Zimmer & Peacock As
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Siemens Healthcare
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Biosensors Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Agamatrix Holdings LLC
  • Abbott Laboratories Inc.
  • Biosensors International Group, Ltd.
  • Medtronic Inc.
  • Bio-Rad Laboratories Inc.
  • Pinnacle Technologies Inc.
  • Ercon, Inc.
  • Dupont Biosensors Materials
  • Koninklijke Philips N.V.
  • Qtl Biodetection LLC.
  • Molecular Devices Corporation
  • Nova Biomedical
  • Molex LLC
  • Zimmer & Peacock As
  • Siemens Healthcare



Table Information